T 1742/19 (Pharmaceutical composition containing an anti-nucleating agent/ MERCK) of 10.11.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T174219.20221110
- Date of decision
- 10 November 2022
- Case number
- T 1742/19
- Petition for review of
- -
- Application number
- 05852790.4
- IPC class
- A61K 9/48A61K 9/20A61K 31/513
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-NUCLEATING AGENT
- Applicant name
- Merck Sharp & Dohme Corp.
- Opponent name
- Ter Meer Steinmeister & Partner Patentanwälte mbB
Georg Kalhammer/Stephan Teipel - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 83
- Keywords
- Main request and auxiliary requests 1-5 - Sufficiency of disclosure (No)
Auxiliary request 6 - Sufficiency of disclosure (Yes)
Auxiliary request 6 - Inventive step (Yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 0091/22
Order
For these reasons it is decided that:
The appeals are dismissed.